| Trial ID: | L1573 |
| Source ID: | NCT01105494
|
| Associated Drug: |
Epoetin Beta [Neorecormon]
|
| Title: |
An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia
|
| Interventions: |
DRUG: epoetin beta [NeoRecormon]
|
| Outcome Measures: |
Primary: Quality of life assessment: Kidney Disease Quality of Life Questionnaire, Throughout study: 6 months | Secondary: Evaluation of factors (demographic and social characteristics, dialysis method) influencing the quality of life, Throughout study: 6 months
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
6000
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-12
|
| Completion Date: |
2012-06
|
| Results First Posted: |
|
| Last Update Posted: |
2012-09-13
|
| Locations: |
Casablanca, 20000, Morocco
|
| URL: |
https://clinicaltrials.gov/show/NCT01105494
|
